AT368502B - Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro(isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzen - Google Patents
Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro(isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzenInfo
- Publication number
- AT368502B AT368502B AT0302677A AT302677A AT368502B AT 368502 B AT368502 B AT 368502B AT 0302677 A AT0302677 A AT 0302677A AT 302677 A AT302677 A AT 302677A AT 368502 B AT368502 B AT 368502B
- Authority
- AT
- Austria
- Prior art keywords
- isobenzofuran
- dihydro
- new
- production
- acid addition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/681,509 US4031224A (en) | 1976-04-29 | 1976-04-29 | 1,3-Dihydro-heteroarylspiro (isobenzofuran)s |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA302677A ATA302677A (de) | 1982-02-15 |
| AT368502B true AT368502B (de) | 1982-10-25 |
Family
ID=24735573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0302677A AT368502B (de) | 1976-04-29 | 1977-04-28 | Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro(isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzen |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4031224A (de) |
| JP (1) | JPS52133974A (de) |
| AT (1) | AT368502B (de) |
| AU (1) | AU517471B2 (de) |
| BE (1) | BE854133A (de) |
| CA (1) | CA1084493A (de) |
| DE (1) | DE2718455A1 (de) |
| DK (1) | DK185977A (de) |
| ES (1) | ES458127A1 (de) |
| FI (1) | FI771337A (de) |
| FR (1) | FR2349587A1 (de) |
| GB (1) | GB1571077A (de) |
| GR (1) | GR71645B (de) |
| IE (1) | IE45037B1 (de) |
| IL (1) | IL51957A0 (de) |
| IT (1) | IT1113573B (de) |
| LU (1) | LU77215A1 (de) |
| NL (1) | NL7704425A (de) |
| NO (1) | NO771442L (de) |
| PT (1) | PT66492B (de) |
| SE (1) | SE7704857L (de) |
| ZA (1) | ZA772548B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4409229A (en) * | 1977-12-02 | 1983-10-11 | Hoechst-Roussel Pharmaceuticals, Inc. | Antidepressive and tranquilizing substituted 1,3-dihydrospiro[benzo(c)thiophene]s |
| MC1315A1 (fr) * | 1979-02-22 | 1981-03-10 | Wellcome Found | Derives de l'imidazole et leur synthese et preparation de medicaments contenant ces substances |
| US4263317A (en) * | 1979-09-06 | 1981-04-21 | Hoechst-Roussel Pharmaceuticals, Inc. | Spiro[cyclohexane-1,1'(3'H)-isobenzofuran]s |
| US5206240A (en) * | 1989-12-08 | 1993-04-27 | Merck & Co., Inc. | Nitrogen-containing spirocycles |
| EP0450761A1 (de) * | 1990-03-02 | 1991-10-09 | Merck & Co. Inc. | Spirocyclische Oxtocin-Antagonisten |
| US5648352A (en) * | 1991-09-13 | 1997-07-15 | Merck & Co., Inc. | Piperazinylcamphorsulfonyl oxytocin antagonists |
| US5693643A (en) * | 1991-09-16 | 1997-12-02 | Merck & Co., Inc. | Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
| US6376505B1 (en) | 1997-05-29 | 2002-04-23 | Eli Lilly And Company | 5-HT1A and 5-HT1Dαdalpha antagonists |
| AU7378698A (en) * | 1997-05-29 | 1998-12-30 | Eli Lilly And Company | 5-ht1a and 5-ht1dalpha antagonists |
| EP2563764B1 (de) * | 2010-04-26 | 2015-02-25 | Merck Sharp & Dohme Corp. | Neue spiropiperidin-prolylcarboxypeptidase-hemmer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959475A (en) * | 1973-12-12 | 1976-05-25 | American Hoechst Corporation | Substituted 1,3-dihydrospiro(isobenzofuran)s |
| US3980787A (en) * | 1975-08-25 | 1976-09-14 | American Hoechst Corporation | 3-Phenylspiro[isobenzofuran-1,4'-piperidine]sulfenamides and derivatives |
-
1976
- 1976-04-29 US US05/681,509 patent/US4031224A/en not_active Expired - Lifetime
-
1977
- 1977-04-22 NL NL7704425A patent/NL7704425A/xx not_active Application Discontinuation
- 1977-04-23 ES ES458127A patent/ES458127A1/es not_active Expired
- 1977-04-26 NO NO771442A patent/NO771442L/no unknown
- 1977-04-26 DE DE19772718455 patent/DE2718455A1/de not_active Withdrawn
- 1977-04-27 SE SE7704857A patent/SE7704857L/xx unknown
- 1977-04-27 FI FI771337A patent/FI771337A/fi not_active Application Discontinuation
- 1977-04-27 IT IT22899/77A patent/IT1113573B/it active
- 1977-04-27 IL IL51957A patent/IL51957A0/xx unknown
- 1977-04-27 LU LU77215A patent/LU77215A1/xx unknown
- 1977-04-27 GR GR53305A patent/GR71645B/el unknown
- 1977-04-28 PT PT66492A patent/PT66492B/de unknown
- 1977-04-28 ZA ZA00772548A patent/ZA772548B/xx unknown
- 1977-04-28 AU AU24647/77A patent/AU517471B2/en not_active Expired
- 1977-04-28 CA CA277,261A patent/CA1084493A/en not_active Expired
- 1977-04-28 GB GB17786/77A patent/GB1571077A/en not_active Expired
- 1977-04-28 IE IE856/77A patent/IE45037B1/en unknown
- 1977-04-28 AT AT0302677A patent/AT368502B/de not_active IP Right Cessation
- 1977-04-28 DK DK185977A patent/DK185977A/da unknown
- 1977-04-28 JP JP4976977A patent/JPS52133974A/ja active Pending
- 1977-04-29 FR FR7713019A patent/FR2349587A1/fr active Granted
- 1977-04-29 BE BE177158A patent/BE854133A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI771337A (de) | 1977-10-30 |
| SE7704857L (sv) | 1977-10-30 |
| JPS52133974A (en) | 1977-11-09 |
| NL7704425A (nl) | 1977-11-01 |
| LU77215A1 (de) | 1977-12-01 |
| BE854133A (fr) | 1977-10-31 |
| IE45037L (en) | 1977-10-29 |
| ZA772548B (en) | 1978-04-26 |
| IL51957A0 (en) | 1977-06-30 |
| IE45037B1 (en) | 1982-06-02 |
| GR71645B (de) | 1983-06-29 |
| NO771442L (no) | 1977-11-01 |
| IT1113573B (it) | 1986-01-20 |
| ES458127A1 (es) | 1978-11-01 |
| ATA302677A (de) | 1982-02-15 |
| AU2464777A (en) | 1978-11-02 |
| FR2349587B1 (de) | 1980-03-07 |
| FR2349587A1 (fr) | 1977-11-25 |
| GB1571077A (en) | 1980-07-09 |
| US4031224A (en) | 1977-06-21 |
| CA1084493A (en) | 1980-08-26 |
| AU517471B2 (en) | 1981-08-06 |
| DE2718455A1 (de) | 1977-11-10 |
| DK185977A (da) | 1977-10-30 |
| PT66492A (de) | 1977-05-01 |
| PT66492B (de) | 1978-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT369017B (de) | Verfahren zur herstellung von neuen derivaten der hydroxycarbonylphosphonsaeure, sowie von deren salzen und optischen antipoden | |
| ATA701479A (de) | Verfahren zur herstellung von neuen chinolinen, chinoxalinen und chanzolinen und deren pharmazeutisch verwendbaren derivaten | |
| ATA889476A (de) | Verfahren zur herstellung von neuen 1-aryl-2-(1 -imidazolyl)-akylsulfiden, von deren saeure- additionssalzen und optisch aktiven ver- bindungen | |
| AT347463B (de) | Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren saeureadditions- salzen | |
| AT368502B (de) | Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro(isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzen | |
| AT355554B (de) | Verfahren zur herstellung von neuen o-(3-amino- 2-hydroxypropyl)-amidoxim-derivaten, deren saeureadditionssalzen und deren optisch aktiven antipoden | |
| AT357558B (de) | Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkyl-benzol- sulfonylharnstoffen und von deren salzen | |
| AT351025B (de) | Verfahren zur herstellung von neuen 1,4-dihydro -pyridinen und deren salzen | |
| AT345995B (de) | Verfahren zur herstellung von neuen octahydroindolochinolizinderivaten, deren salzen und optischen antipoden | |
| ATA112277A (de) | Verfahren zur herstellung von neuen 2,9-dioxa- tricyclo (4,3,1,03,7) decanen und deren salzen | |
| AT364842B (de) | Verfahren zur herstellung von neuen octahydroindolo(2,3-a)chinolizinen, deren saeureadditionssalzen und optischen antipoden | |
| ATA358880A (de) | Verfahren zur herstellung von neuen 15-halogen-e- homoeburnanderivaten, von deren saeureadditions- salzen, epimeren und optischen antipoden | |
| AT346825B (de) | Verfahren zur herstellung von neuen 3- aminomethyl-2-phenylbicyclo(2,2,2)octanen und -octenen und deren saeureadditionssalzen | |
| ATA107077A (de) | Verfahren zur herstellung von neuen 2,2-dimethyl-3-(2',2'-dicklorvinyl)- cyclopropan-carbonsaeure-derivaten | |
| AT342565B (de) | Verfahren zur herstellung von neuen 3,4-dichlorphenon-o-(2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| ATA559778A (de) | Verfahren zur herstellung von neuen 1,2- -benzisothiazolen und deren saeureadditions- salzen | |
| AT352735B (de) | Verfahren zur herstellung von neuen 2,4- diamino-5-benzylpyrimidinen und deren saeure- additionssalzen | |
| ATA577177A (de) | Verfahren zur herstellung von neuen optisch aktiven derivaten des d-threo-1-phenyl-2- trifluoracetamidopropandiols-(1,3) | |
| AT352136B (de) | Verfahren zur herstellung von neuen 1,5,10,10a- tetrahydrothiazolo-(3,4-b) -isochinolin-derivaten und von deren saeure- additionssalzen | |
| ATA296479A (de) | Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkylbenzolsul- fonylharnstoffen und von deren salzen | |
| ATA136680A (de) | Verfahren zur herstellung von neuen imidazol- derivaten ihren optischen antipoden und saeureadditionssalzen | |
| ATA76778A (de) | Verfahren zur herstellung von neuen arali- phatischen morpholinoverbindungen, deren saeureadditionssalzen und optisch aktiven ver- bindungen | |
| AT381313B (de) | Verfahren zur herstellung von neuen indolochinolizin-derivaten, von deren salzen und von deren optischen antipoden | |
| ATA20678A (de) | Verfahren zur herstellung von neuen 1- nitrotolyloxy-3-tert.butylaminopropan-2-olen und deren saeureadditionssalzen | |
| ATA440579A (de) | Verfahren zur herstellung von neuen 3-amino- methyl-4beta-hydroxy-2,9-dioxatricyclo(4,3,1, 03,7)decanen und deren salzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| ELJ | Ceased due to non-payment of the annual fee |